| Description of combined ARHSP/JALS phenotype in some patients with SPG11 mutations M Khani, H Shamshiri, F Fatehi, M Rohani, B Haghi Ashtiani, ... Molecular Genetics & Genomic Medicine 8 (7), e1240, 2020 | 10 | 2020 |
| Continuum of phenotypes in hereditary motor and sensory neuropathy with proximal predominance and Charcot–Marie–Tooth patients with TFG mutation M Khani, H Taheri, H Shamshiri, H Houlden, S Efthymiou, A Alavi, ... American Journal of Medical Genetics Part A 179 (8), 1507-1515, 2019 | 9 | 2019 |
| BVVL/FL: features caused by SLC52A3 mutations; WDFY4 and TNFSF13B may be novel causative genes M Khani, H Shamshiri, H Taheri, J Hardy, JT Bras, S Carmona, ... Neurobiology of Aging 99, 102. e1-102. e10, 2021 | 8 | 2021 |
| Targeting OCT2 with duloxetine to prevent oxaliplatin-induced peripheral neurotoxicity MR Nepal, H Taheri, Y Li, Z Talebi, ME Uddin, Y Jin, DF DiGiacomo, ... Cancer research communications 2 (11), 1334-1343, 2022 | 4 | 2022 |
| A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities Y Li, Y Jin, H Taheri, KT Schmidt, AA Gibson, SAJ Buck, ED Eisenmann, ... Pharmaceutics 14 (9), 1933, 2022 | 3 | 2022 |
| Deep geno-and phenotyping in two consanguineous families with CMT2 reveals HADHA as an unusual disease-causing gene and an intronic variant in GDAP1 as an unusual mutation M Khani, H Taheri, H Shamshiri, H Moazzeni, J Hardy, JT Bras, ... Journal of Neurology 268, 640-650, 2021 | 2 | 2021 |
| Quantification of the aromatase inhibitor letrozole and its carbinol metabolite in mouse plasma by UHPLC-MS/MS H Taheri, Y Jin, E Ahmed, P Hu, Y Li, A Sparreboom, S Hu Journal of Chromatography B 1238, 124106, 2024 | 1 | 2024 |
| Identification of RNF13 as cause of recessively inherited ALS in a multi-case pedigree M Khani, S Nafissi, H Shamshiri, H Moazzeni, H Taheri, E Elahi Journal of Medical Genetics 60 (3), 301-309, 2023 | 1 | 2023 |
| Identification of UBA1 as the causative gene of an X‐linked non‐Kennedy spinal–bulbar muscular atrophy M Khani, S Nafissi, H Shamshiri, H Moazzeni, H Taheri, M Sadeghi, ... European Journal of Neurology 29 (12), 3556-3563, 2022 | 1 | 2022 |
| A case of adult onset Sandhoff disease that mimics Brown-Vialetto-Van Laere syndrome M Khani, H Shamshiri, H Moazzeni, H Taheri, H Ahmadieh, A Alavi, ... Neuromuscular Disorders 31 (6), 528-531, 2021 | 1 | 2021 |
| Identification of a mutation in TNRC18 in a patient with clinical features of Fazio‐Londe disease M Khani, H Shamshiri, S Nafissi, N Salehi, H Moazzeni, H Taheri, E Elahi Clinical Case Reports 12 (1), e8394, 2024 | | 2024 |
| PREVENTION OF OXALIPLATIN NEUROPATHY BY DULOXETINE-MEDIATED OCT2 INHIBITION. M Nepal, H Taheri, Y Li, A Gibson, M Uddin, A Sparreboom, S Hu CLINICAL PHARMACOLOGY & THERAPEUTICS 111, S64-S64, 2022 | | 2022 |
| Discovery and validation of OATP1B biomarkers for predicting transporter mediated drug-drug interactions Y Li, H Taheri, Y Jin, AA Gibson, ED Eisenmann, SD Baker, ... | | |
